Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across ...

In the first in a new series of executive interviews, we quiz MG's chief commercial officer about utes, luxury cars and the ...

I turned off my TV to instead fire up a portable projector for binging shows and watching sports — and I wish I had made that decision years earlier.

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Sam, the host of the "Sam CarLegion" channel on YT, has prepared yet another drag-and-roll race skirmish - PHEV versus two ...

Want a premium small car but not sure whether to join the EV revolution or stick with what you know? We compare the MG 4 with ...

ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 ...

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...

In this post-pandemic world, it’s surprisingly (and frustratingly) rare to find a new car for under $30,000. Various factors are responsible, including emissions rules and the inexorable popularity of ...

Key Laboratory for Ecological Metallurgy of Multimetallic Mineral (Ministry of Education), School of Metallurgy, Northeastern University, Shenyang 110819, China Liaoning Key Laboratory for ...

The arrival of the MG Cyberster marks a significant moment in ... and a supercar-baiting 3.2-second sprint time. A practical range and useful rapid charging ability boost the Cyberster’s GT ...